Halozyme Therapeutics
HALO
$39.12
Share price
0.38%
Change (1 day)
16.64%
Change (1 year)
Categories
Number of shares outstanding for Halozyme Therapeutics (HALO)
Number of shares outstanding as of April 2024 : 131,965,000
According to Halozyme Therapeutics's latest financial reports and stock price the company's current number of shares outstanding is 131,965,000. At the end of 2023 the company had 131,965,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Halozyme Therapeutics from 2002 to 2023
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2023 | 0.13 B | -2.45% |
| 2022 | 0.13 B | -3.52% |
| 2021 | 0.14 B | 3.79% |
| 2020 | 0.13 B | -4.21% |
| 2019 | 0.14 B | -2.19% |
| 2018 | 0.14 B | 1.75% |
| 2017 | 0.14 B | 10.56% |
| 2016 | 0.12 B | 0.78% |
| 2015 | 0.12 B | 2.35% |
| 2014 | 0.12 B | 9.44% |
| 2013 | 0.11 B | 1.09% |
| 2012 | 0.11 B | 8.81% |
| 2011 | 0.10 B | 10.26% |
| 2010 | 93.62 M | 4.53% |
| 2009 | 89.57 M | 11.55% |
| 2008 | 80.29 M | 4.96% |
| 2007 | 76.5 M | 21.95% |
| 2006 | 62.73 M | 25.52% |
| 2005 | 49.97 M | 26.29% |
| 2004 | 39.57 M | 382.82% |
| 2003 | 8.19 M | 327.5% |
| 2002 | 1.91 M |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 2,407,200,000 | 1,724.12% | 🇺🇸 USA |
 Pfizer PFE | 5,647,000,000 | 4,179.16% | 🇺🇸 USA |
 Eli Lilly LLY | 949,379,000 | 619.42% | 🇺🇸 USA |
 Sanofi SNY | 2,507,200,000 | 1,799.90% | 🇫🇷 France |
 Baxter BAX | 507,000,000 | 284.19% | 🇺🇸 USA |
 MannKind Corp MNKD | 268,732,000 | 103.64% | 🇺🇸 USA |